Articles by R. Gary Hollenbeck - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by R. Gary Hollenbeck

R. Gary Hollenbeck

R. Gary Hollenbeck, PhD, is chief scientific officer at UPm Pharmaceuticals, adjunct professor of pharmaceutical sciences at the University of maryland school of Pharmacy, and a member of Pharmaceutical Technology's editorial advisory Board, 6200 Seaforth St., Baltimore, MD, 21224, tel. 410.843.3745.

Are You Ready for REMS?
October 2, 2008

A book offers a detailed introduction to the new area of risk evaluation and mitigation strategies.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here